{"id":3250,"date":"2012-10-04T06:30:00","date_gmt":"2012-10-04T06:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\/"},"modified":"2012-10-04T06:30:00","modified_gmt":"2012-10-04T06:30:00","slug":"xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\/","title":{"rendered":"Xvivo Perfusion AB upptas till handel p\u00e5 NASDAQ OMX First North den 8 oktober 2012."},"content":{"rendered":"<p><span>Den 1 oktober knoppades Xvivo Perfusion AB av fr\u00e5n Vitrolife AB d\u00e4r aktie\u00e4garna i Vitrolife erh\u00f6ll en aktie i Xvivo Perfusion f\u00f6r varje aktie i Vitrolife. Xvivo Perfusions aktie har godk\u00e4nts f\u00f6r handel p\u00e5 NASDAQ OMX First North med f\u00f6rsta handelsdag den 8 oktober. <\/span><\/p>\n<p><span>Med anledningen av listningen p\u00e5 First North publicerar Xvivo Perfusion idag en bolagsbeskrivning som finns tillg\u00e4nglig p\u00e5 bolagets hemsida.<\/span><\/p>\n<p><span>G\u00f6teborg 4 oktober 2012<br \/><\/span><span>Xvivo Perfusion AB (publ)<br \/><\/span><span>Magnus Nilsson<br \/><\/span><span>Verkst\u00e4llande direkt\u00f6r<\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span>F\u00f6r ytterligare information kontakta: <\/span><br \/><span>Magnus Nilsson, CEO eller Christoffer Rosenblad, CFO Xvivo Perfusion AB<\/span><br \/><span>telefon 031-788 21 50 (v\u00e4xel) eller 031-788 21 59 (Christoffer direkt) <\/span><\/p>\n<p><span>Informationen l\u00e4mnades f\u00f6r publicering den 4 oktober 2012 kl. 08:30.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Den 1 oktober knoppades Xvivo Perfusion AB av fr\u00e5n Vitrolife AB d\u00e4r aktie\u00e4garna i Vitrolife erh\u00f6ll en aktie i Xvivo&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-3250","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Xvivo Perfusion AB upptas till handel p\u00e5 NASDAQ OMX First North den 8 oktober 2012. - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xvivo Perfusion AB upptas till handel p\u00e5 NASDAQ OMX First North den 8 oktober 2012. - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Den 1 oktober knoppades Xvivo Perfusion AB av fr\u00e5n Vitrolife AB d\u00e4r aktie\u00e4garna i Vitrolife erh\u00f6ll en aktie i Xvivo...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\\\/\",\"name\":\"Xvivo Perfusion AB upptas till handel p\u00e5 NASDAQ OMX First North den 8 oktober 2012. - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2012-10-04T06:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xvivo Perfusion AB upptas till handel p\u00e5 NASDAQ OMX First North den 8 oktober 2012.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xvivo Perfusion AB upptas till handel p\u00e5 NASDAQ OMX First North den 8 oktober 2012. - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\/","og_locale":"en_US","og_type":"article","og_title":"Xvivo Perfusion AB upptas till handel p\u00e5 NASDAQ OMX First North den 8 oktober 2012. - XVIVO","og_description":"Den 1 oktober knoppades Xvivo Perfusion AB av fr\u00e5n Vitrolife AB d\u00e4r aktie\u00e4garna i Vitrolife erh\u00f6ll en aktie i Xvivo...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\/","name":"Xvivo Perfusion AB upptas till handel p\u00e5 NASDAQ OMX First North den 8 oktober 2012. - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2012-10-04T06:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-ab-upptas-till-handel-pa-nasdaq-omx-first-north-den-8-oktober-2012\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Xvivo Perfusion AB upptas till handel p\u00e5 NASDAQ OMX First North den 8 oktober 2012."}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}